drugset
drugset / Trial / NCT01154374

A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)

NCT01154374 ↗

Phase 2 Completed 7 enrolled Skingenix, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).

Timeline

Start
2010-11
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject MEBO Wound Ointment Unknown — Topical

Indications

ulcer of lower limbs